Allt inom Report
Nanexa publishes interim report for January-March 2026
Opened the year with strong preclinical results for once-monthly and quarterly dosing of semaglutide
Nanexa publishes annual report for 2025
Nanexa AB (publ) today announces that the Annual Report for 2025 has been published and is available on the company's website Nanexa AB – Financial reports.